Annual Retained Earnings
-$615.71 M
-$78.95 M-14.71%
31 December 2023
Summary:
Protagonist Therapeutics annual retained earnings is currently -$615.71 million, with the most recent change of -$78.95 million (-14.71%) on 31 December 2023. During the last 3 years, it has fallen by -$331.90 million (-116.94%). PTGX annual retained earnings is now -4802.93% below its all-time high of -$12.56 million, reached on 31 December 2014.PTGX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$472.20 M
-$33.21 M-7.57%
30 September 2024
Summary:
Protagonist Therapeutics quarterly retained earnings is currently -$472.20 million, with the most recent change of -$33.21 million (-7.57%) on 30 September 2024. Over the past year, it has increased by +$170.85 million (+26.57%). PTGX quarterly retained earnings is now -1622.34% below its all-time high of -$27.42 million, reached on 31 December 2015.PTGX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.7% | +26.6% |
| 3 y3 years | -116.9% | -26.8% |
| 5 y5 years | -338.3% | -135.9% |
PTGX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -116.9% | at low | -26.8% | +26.6% |
| 5 y | 5 years | -338.3% | at low | -135.9% | +26.6% |
| alltime | all time | -4802.9% | at low | -1622.3% | +26.6% |
Protagonist Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$472.20 M(+7.6%) |
| June 2024 | - | -$438.99 M(+7.5%) |
| Mar 2024 | - | -$408.37 M(-33.7%) |
| Dec 2023 | -$615.71 M(+14.7%) | -$615.71 M(-4.3%) |
| Sept 2023 | - | -$643.04 M(+5.6%) |
| June 2023 | - | -$608.94 M(+6.7%) |
| Mar 2023 | - | -$570.48 M(+6.3%) |
| Dec 2022 | -$536.75 M(+31.1%) | -$536.75 M(+6.8%) |
| Sept 2022 | - | -$502.56 M(+6.6%) |
| June 2022 | - | -$471.33 M(+9.5%) |
| Mar 2022 | - | -$430.29 M(+5.1%) |
| Dec 2021 | -$409.36 M(+44.2%) | -$409.36 M(+9.9%) |
| Sept 2021 | - | -$372.45 M(+10.0%) |
| June 2021 | - | -$338.65 M(+10.0%) |
| Mar 2021 | - | -$307.81 M(+8.5%) |
| Dec 2020 | -$283.81 M | -$283.81 M(+7.1%) |
| Sept 2020 | - | -$264.93 M(+3.0%) |
| June 2020 | - | -$257.16 M(+8.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$237.74 M(+9.2%) |
| Dec 2019 | -$217.66 M(+54.9%) | -$217.66 M(+8.7%) |
| Sept 2019 | - | -$200.16 M(+8.9%) |
| June 2019 | - | -$183.75 M(+18.9%) |
| Mar 2019 | - | -$154.58 M(+10.0%) |
| Dec 2018 | -$140.47 M(+38.3%) | -$140.47 M(+11.0%) |
| Sept 2018 | - | -$126.61 M(+7.4%) |
| June 2018 | - | -$117.87 M(+7.9%) |
| Mar 2018 | - | -$109.21 M(+7.5%) |
| Dec 2017 | -$101.55 M(+57.2%) | -$101.55 M(+3.1%) |
| Sept 2017 | - | -$98.50 M(+5.2%) |
| June 2017 | - | -$93.67 M(+19.0%) |
| Mar 2017 | - | -$78.69 M(+21.8%) |
| Dec 2016 | -$64.59 M(+135.6%) | -$64.59 M(+21.1%) |
| Sept 2016 | - | -$53.34 M(+15.3%) |
| June 2016 | - | -$46.26 M(+18.1%) |
| Mar 2016 | - | -$39.16 M(+42.8%) |
| Dec 2015 | -$27.42 M(+118.3%) | -$27.42 M |
| Dec 2014 | -$12.56 M | - |
FAQ
- What is Protagonist Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Protagonist Therapeutics?
- What is Protagonist Therapeutics annual retained earnings year-on-year change?
- What is Protagonist Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Protagonist Therapeutics?
- What is Protagonist Therapeutics quarterly retained earnings year-on-year change?
What is Protagonist Therapeutics annual retained earnings?
The current annual retained earnings of PTGX is -$615.71 M
What is the all time high annual retained earnings for Protagonist Therapeutics?
Protagonist Therapeutics all-time high annual retained earnings is -$12.56 M
What is Protagonist Therapeutics annual retained earnings year-on-year change?
Over the past year, PTGX annual retained earnings has changed by -$78.95 M (-14.71%)
What is Protagonist Therapeutics quarterly retained earnings?
The current quarterly retained earnings of PTGX is -$472.20 M
What is the all time high quarterly retained earnings for Protagonist Therapeutics?
Protagonist Therapeutics all-time high quarterly retained earnings is -$27.42 M
What is Protagonist Therapeutics quarterly retained earnings year-on-year change?
Over the past year, PTGX quarterly retained earnings has changed by +$170.85 M (+26.57%)